NEW YORK (GenomeWeb News) – Qiagen's acquisition last week of additional PCR licenses from Roche and Idaho Technology will bolster the company's PCR business on several fronts, including hardware, consumables, and in vitro diagnostics, according to a company official.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.